FDA Approved: LACOSAMIDE — Supplemental Application (XLCare Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for lacosamide submitted by XLCare Pharmaceuticals Inc., updating the product labeling under the existing approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial-onset Seizures

Drugs mentioned

• Lacosamide (Lacosamide)

Snippet

SUPPL AP for LACOSAMIDE (LACOSAMIDE)